EC Number   |
Activating Compound |
Reference  |
|---|
   2.7.3.2 | NADH |
lowers Km for phosphocreatine 3fold |
642417 |
| 2.7.3.2 | aripiprazole |
activation of enzyme in striatum and cerebral cortex after chronic administration at 10 or 20 mg/kg. No effect on enzyme in hippocampus, cerebellum and prefrontal cortex |
671679 |
| 2.7.3.2 | olanzapine |
activation of enzyme in striatum after chronic administration at 10 mg/kg |
671679 |
| 2.7.3.2 | ADP |
activation of creatine kinase and induction of a state 3-like respiration in isolated brain mitochondria, and prevention of H2O2 production obeys the steady-state kinetics of the enzyme to phosphorylate creatine |
674713 |
| 2.7.3.2 | ATP |
activation of creatine kinase and induction of a state 3-like respiration in isolated brain mitochondria, and prevention of H2O2 production obeys the steady-state kinetics of the enzyme to phosphorylate creatine |
674713 |
| 2.7.3.2 | Creatine |
activation of creatine kinase and induction of a state 3-like respiration in isolated brain mitochondria, and prevention of H2O2 production obeys the steady-state kinetics of the enzyme to phosphorylate creatine |
674713 |
| 2.7.3.2 | trans-[RuCl2(3,4-pyridinedicarboxylic acid)4] |
administration at 180.7 micromol/kg, increase of creatine kinase activity in hippocampus, striatum, cerebral cortex and heart, but not in skeletal muscle. No effect on enzyme in vitro |
675240 |
| 2.7.3.2 | trans-[RuCl2(3,5-pyridinedicarboxylic acid)4] |
administration at 180.7 micromol/kg, increase of creatine kinase activity in hippocampus, striatum, cerebral cortex and heart, but not in skeletal muscle. No effect on enzyme in vitro |
675240 |
| 2.7.3.2 | more |
increase of enzymatic activity post-exercise |
697687 |
| 2.7.3.2 | 20(R)-protopanaxadiol |
23.5% increase of activity at 0.02 mM |
760706 |
